Biophysics offers an abundance of techniques and assays, each with their own benefits and challenges, but knowing which to use, when to use it, and how to evolve your assay strategy across discovery phases is a constant challenge. This interactive workshop brings together early discovery scientists from pharma and biotech to share practical decision-making frameworks for building high-confidence assay cascades.

Join this workshop to:

• Explore practical strategies for designing cascades that evolve with program maturity
• Uncover exclusive insights into trade-offs between throughput, resolution, and confidence in hit identification
• Discuss approaches for choosing between overlapping or orthogonal assays (e.g., SPR vs BLI vs ITC)
• Hear real-world examples from both pharma and biotechs of how assay source (fragment screens, DEL, HTS) and target type influence cascade design
• Extract tips to interpret conflicting data and avoid common pitfalls

Why Take Part?

Leave with practical insights on how to design, adapt, and troubleshoot their own screening workflows according to target class, modality, throughput needs, and data quality.